OCUL
Ocular Therapeutix Inc
NASDAQ: OCUL · HEALTHCARE · BIOTECHNOLOGY
$9.21
-1.18% today
Updated 2026-04-29
Market cap
$2.00B
P/E ratio
—
P/S ratio
38.59x
EPS (TTM)
$-1.42
Dividend yield
—
52W range
$6 – $16
Volume
4.9M
Ocular Therapeutix Inc (OCUL) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-9.4%
Last 4 quarters
Revenue YoY growth
-22.4%
Most recent quarter
EPS YoY growth
+0.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+1.0%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+7.1%
2026-02-05
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-05 | $-0.29 | +9.4% | $8.55 | $9.16 | +7.1% |
| 2025-11-04 | $-0.38 | -2.7% | $11.41 | $10.81 | -5.3% |
| 2025-08-05 | $-0.39 | -11.4% | $12.35 | $12.50 | +1.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.32 | $-0.29 | +9.4% | $13.25M | -22.4% |
| 2025-09-30 | $-0.37 | $-0.38 | -2.7% | $14.54M | -5.7% |
| 2025-06-30 | $-0.35 | $-0.39 | -11.4% | $13.46M | -18.1% |
| 2025-03-31 | $-0.28 | $-0.37 | -33.0% | $10.70M | -27.6% |
| 2024-12-31 | $-0.22 | $-0.29 | -31.8% | $17.08M | +15.4% |
| 2024-09-30 | $-0.24 | $-0.22 | +8.3% | $15.43M | +2.3% |
| 2024-06-30 | $-0.22 | $-0.26 | -18.2% | $16.44M | +8.3% |
| 2024-03-31 | $-0.19 | $-0.70 | -268.4% | $14.77M | — |
| 2023-12-31 | $-0.30 | $-0.35 | -16.7% | $14.80M | — |
| 2023-09-30 | $-0.29 | $-0.17 | +41.4% | $15.08M | — |
| 2023-06-30 | $-0.30 | $-0.26 | +13.3% | $15.19M | — |
Frequently asked questions
Has Ocular Therapeutix Inc beaten earnings estimates?
Ocular Therapeutix Inc has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -9.4% over the last 4 quarters.
How does OCUL stock react to earnings?
OCUL stock has moved an average of +1.0% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is Ocular Therapeutix Inc's revenue growth rate?
Ocular Therapeutix Inc reported year-over-year revenue growth of -22.4% in its most recent quarter, with EPS growing +0.0% year-over-year.